While recent studies have discovered FRK-mediated growth-regulatory properties in the liver and pancreatic cancers, the tumor suppressor properties of FRK have been well studied in breast and glial cancers ([6], [7] and reviewed in [1]). The gene discussed is FRK; the disease is familial pancreatic carcinoma.